Delcath Systems Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Delcath Systems Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Delcath Systems Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Delcath Systems Inc. is DCTH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Delcath Systems Inc. has its primary listing on NASDAQ (Small cap). You can trade Delcath Systems Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Delcath Systems Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Delcath Systems Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Delcath Systems Inc..